Gennadi V Glinsky

7PUBLICATIONS
10CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Nanotoxicology, health and safetyMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 17, 2025
Transposable Elements Seed Transcription Factor Binding Sites to Sequence-Specific Double-Stranded DNA Binding TF Networks Contributing to Governance of Primate Brain Evolution.

Gennadi V Glinsky

|Oct 31, 2025
RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022, 10, 795.

Thangirala Sudha, Kavitha Godugu, Gennadi V Glinsky

|Sep 19, 2022
Molecular diversity and phenotypic pleiotropy of ancient genomic regulatory loci derived from human endogenous retrovirus type H (HERVH) promoter LTR7 and HERVK promoter LTR5_Hs and their contemporary impacts on pathophysiology of Modern Humans.

Gennadi V Glinsky

|Jun 28, 2022
Rapid self-test of unprocessed viruses of SARS-CoV-2 and its variants in saliva by portable wireless graphene biosensor.

Deependra Kumar Ban, Tyler Bodily, Abhijith G Karkisaval

|Apr 23, 2022
RETRACTED: Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer.

Thangirala Sudha, Kavitha Godugu, Gennadi V Glinsky

|Apr 21, 2022
Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.

Gennadi V Glinsky, Kavitha Godugu, Thangirala Sudha

Pageof 2

Frequent Collaborators

3 joint publications

Shaker A Mousa

1 joint publications

Deependra Kumar Ban

1 joint publications

Tyler Bodily

1 joint publications

Abhijith G Karkisaval